Cannabinoid Hyperemesis Syndrome CHS: Causes, Symptoms & Treatment

weed chs

Organizations focused on marijuana health offer counseling and rehabilitation services specifically designed for marijuana users. These services not only address the urgent signs of CHS but also help individuals navigate the complexities of marijuana use and its related health risks. Accessing these resources through Leafy Mate can be a pivotal step toward recovery, empowering you to learn how long it takes to recover from cannabinoid hyperemesis syndrome and regain control over your health and well-being. At Leafy Mate, we prioritize education and accessibility to empower users with the knowledge they weed chs need to navigate the complexities of cannabis-related health issues.

Wellness Phase

Furthermore, some authors have reported referring patients to drug rehabilitation programs in an attempt to raise the likelihood of long-term cannabis cessation 54,71. Studies have demonstrated the efficacy of outpatient treatment options such as cognitive behavioral therapy and motivational enhancement therapy for marijuana dependence 73. Patients with CHS usually remain misdiagnosed for a considerable time period. In one case series the average number of emergency room visits (7.1 ± 4.3) prior to diagnosis and the delay in diagnosis (for up to 9 years) was substantial 62. Not surprisingly, the early identification of patients with CHS leads to a reduction in morbidity and costs 6. The initial approach to evaluate a patient with cyclical vomiting should start by excluding these vast disorders.

weed chs

Cannabinoid Hyperemesis Syndrome Treatment Guidelines

weed chs

Habboushe concluded in his study that as many as 2.75 million regular cannabis users may suffer from symptoms of CHS, though many of them may be mild. Mild symptoms can serve as a warning to discontinue cannabis use to avoid more severe distress down alcoholism the line, Habboushe said. There was a significant overlap in the sorting of articles into the categories of diagnosis, pathophysiology, and treatment. Thus, some articles were classified in more than one category. We identified 116 articles related to diagnosis, 61 to pathophysiology, and 13 to treatment. There were 24 animal studies related to pathophysiology 84–107.

Are there complications of cannabinoid hyperemesis syndrome?

  • Experts also aren’t clear on what causes CHS, or why some people develop it while others don’t.
  • Despite the scarcity of randomized controlled trials (RCTs) on optimal treatment approaches for CHS, a holistic care plan can significantly enhance patient outcomes and well-being.
  • However, with the underlying condition left untreated, CHS can cause serious medical issues.
  • The pro-emetic effects of two of these cannabinoids, CBD and CBG, have been discussed in this review and could conceivably play a role in the development of CHS.
  • In the evolving landscape of cannabis consumption, Cannabinoid Hyperemesis Syndrome (CHS) has emerged as a significant public health concern, particularly among chronic users.

If this use began in your early adolescence, the risk increases. The disorder confuses many medical experts because the primary ingredient in marijuana, THC, has anti-nausea effects. In fact, the cannabinoid medications dronabinol and nabilone have been approved by the Food and Drug Administration to treat nausea caused by chemotherapy.

Torna in alto